Drug profile · INN
omecamtiv mecarbil
KINHARTO
omecamtiv mecarbil (KINHARTO) is a cardiac myosin activator.
EMA: application withdrawn Cardiovascular system (C01) C01CX10
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — omecamtiv mecarbil
- Class
- Cardiovascular system (C01)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
omecamtiv mecarbil (KINHARTO) is a cardiac myosin activator.
Key facts
INN omecamtiv mecarbil
Brand KINHARTO
Mechanism Cardiac myosin activator
Target Cardiac myosin
Therapeutic class Cardiovascular system (C01)
ATC code C01CX10
Mechanism of action
Cardiac myosin activator
Primary target: Cardiac myosin
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | application withdrawn | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is omecamtiv mecarbil?
omecamtiv mecarbil (KINHARTO) is a cardiac myosin activator.
What is the brand name for omecamtiv mecarbil?
KINHARTO is a marketed brand name for omecamtiv mecarbil. Check FDA Drugs@FDA for the current US label holder and prescribing information.